Latest News & Features
Americas
IP and innovation in Mexico has come a long way, and the country’s part in international trade treaties will provide further great opportunities, says Nuria Becerril of Becerril, Coca & Becerril. 10 June 2016
Asia-Pacific
There are clear rules on the use of patient data in clinical trials in Costa Rica, as well as sanctions for any breaches, explain María del Pilar López and Esteban Monge of Zürcher Lawyers. 10 June 2016
Asia
India needs to focus more resources on evaluating applications for biologic drugs, while the biosimilar system needs to be tweaked, says Archana Shanker of Anand and Anand. 9 June 2016
Americas
The system governing access to genetic resources in Brazil has been strengthened by a recent legal update, explain Andrea Granthon and Tatiana Schuenck of Luiz Leonardos & Advogados. 9 June 2016
Asia
An Indian company is working on two approaches to creating a vaccine for the Zika virus, while several trademark applications have been filed for the term. Lucy Rana
of SS Rana reports. 8 June 2016
Africa
Africa Harvest is working towards reducing hunger and poverty in some of the world’s poorest countries. Dr Florence Wambugu, founder of the organisation, tells LSIPR more about its work. 8 June 2016
Americas
Aided by strong patent protection, efforts are continuing in Brazil to develop a vaccine against the notorious dengue fever. Gabriel Di Blasi of Di Blasi, Parente & Associados and Jorge Kalil of the Instituto Butantan explain more. 8 June 2016
Americas
There are several rules to watch out for when seeking patent protection for antibodies in Brazil, as Kene Gallois of Daniel Advogados reports. 8 June 2016
Americas
Merial, which is well-known for making products that kill fleas and ticks on cats and dogs, faces a number of challenges on the IP front, as global head of IP Dr Judy Jarecki-Black, tells LSIPR. 7 June 2016
Big Pharma
EPO case law suggests that inventions covering homeopathic medicines do not have to meet a higher bar of patentability than conventional medicaments, but it still must be shown that the claimed products lead to the alleged therapeutic effect. André Guder of Uexküll & Stolberg reports. 7 June 2016